Is Latigo Biotherapeutics Inc. overvalued?

Latigo Biotherapeutics Inc. (LTGO) — key valuation metrics and fundamentals.

No verdict

Price

$13.11

Fair value

—

Current P/E

—

Normal P/E

—

Market cap

$788.6M

Dividend yield

0.0%

Return on equity

—

Sector

Healthcare

Fair value compares LTGO's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 12 Nov 2026.

Related stocks